145 related articles for article (PubMed ID: 36273237)
1. RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer.
Nakazato A; Mochizuki M; Shibuya-Takahashi R; Fujimori H; Fujii K; Saijoh S; Morita S; Yamazaki T; Imai T; Sato I; Satoh K; Yamaguchi K; Sugamura K; Yasuda J; Matsuura K; Shojaku H; Asada Y; Tamai K
Sci Rep; 2022 Oct; 12(1):17751. PubMed ID: 36273237
[TBL] [Abstract][Full Text] [Related]
2. CD271 defines a stem cell-like population in hypopharyngeal cancer.
Imai T; Tamai K; Oizumi S; Oyama K; Yamaguchi K; Sato I; Satoh K; Matsuura K; Saijo S; Sugamura K; Tanaka N
PLoS One; 2013; 8(4):e62002. PubMed ID: 23626764
[TBL] [Abstract][Full Text] [Related]
3. CD271 regulates the proliferation and motility of hypopharyngeal cancer cells.
Mochizuki M; Tamai K; Imai T; Sugawara S; Ogama N; Nakamura M; Matsuura K; Yamaguchi K; Satoh K; Sato I; Motohashi H; Sugamura K; Tanaka N
Sci Rep; 2016 Jul; 6():30707. PubMed ID: 27469492
[TBL] [Abstract][Full Text] [Related]
4. CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma.
Mochizuki M; Nakamura M; Sibuya R; Okazaki T; Abe J; Nakagawa T; Takahashi S; Yamazaki T; Imai T; Takano A; Ito H; Yokose T; Miyagi Y; Daigo Y; Sato I; Satoh K; Sugamura K; Yamaguchi K; Tamai K
Lab Invest; 2019 Sep; 99(9):1349-1362. PubMed ID: 31019292
[TBL] [Abstract][Full Text] [Related]
5. Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells.
Morita S; Mochizuki M; Wada K; Shibuya R; Nakamura M; Yamaguchi K; Yamazaki T; Imai T; Asada Y; Matsuura K; Sugamura K; Katori Y; Satoh K; Tamai K
Cancer Lett; 2019 Oct; 461():144-152. PubMed ID: 31325530
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a monoclonal antibody against glycosylated CD271 specific for cancer cells in immunohistochemistry.
Fujii K; Morita S; Mochizuki M; Shibuya-Takahashi R; Fujimori H; Yamaguchi K; Abe J; Yamazaki T; Imai T; Sugamura K; Yasuda J; Satoh K; Sato I; Saito-Koyama R; Fujishima F; Sasano H; Kato Y; Matsuura K; Asada Y; Tamai K
Cancer Sci; 2022 Aug; 113(8):2878-2887. PubMed ID: 35343032
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CD271 transcriptome in breast cancer promotes cell survival via NFκB pathway.
Bashir N; Ishfaq M; Mazhar K; Khan JS; Shahid R
Mol Biol Rep; 2022 Jan; 49(1):487-495. PubMed ID: 34755264
[TBL] [Abstract][Full Text] [Related]
8. CD271 promotes proliferation and migration in bladder cancer.
Myoen S; Mochizuki M; Shibuya-Takahashi R; Fujimori H; Shindo N; Yamaguchi K; Yasuda J; Abe J; Imai T; Sato I; Adachi H; Kawamura S; Ito A; Tamai K
Genes Cells; 2024 Jan; 29(1):73-85. PubMed ID: 38016691
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor kappaB controls acetylcholine receptor clustering at the neuromuscular junction.
Wang J; Fu XQ; Lei WL; Wang T; Sheng AL; Luo ZG
J Neurosci; 2010 Aug; 30(33):11104-13. PubMed ID: 20720118
[TBL] [Abstract][Full Text] [Related]
10. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
[TBL] [Abstract][Full Text] [Related]
11. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
13. IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity.
Fukuda M; Ehara M; Suzuki S; Ohmori Y; Sakashita H
Int J Oncol; 2010 Jun; 36(6):1355-65. PubMed ID: 20428758
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription.
Mukherjee SP; Behar M; Birnbaum HA; Hoffmann A; Wright PE; Ghosh G
PLoS Biol; 2013 Sep; 11(9):e1001647. PubMed ID: 24019758
[TBL] [Abstract][Full Text] [Related]
15. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
16. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Calcium-Binding Protein S100A9 Inhibits Hypopharyngeal Cancer Cell Proliferation and Invasion Ability Through Inactivation of NF-κB Signaling.
Wu P; Quan H; Kang J; He J; Luo S; Xie C; Xu J; Tang Y; Zhao S
Oncol Res; 2017 Nov; 25(9):1479-1488. PubMed ID: 28276321
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells.
Ushita M; Saito T; Ikeda T; Yano F; Higashikawa A; Ogata N; Chung U; Nakamura K; Kawaguchi H
Osteoarthritis Cartilage; 2009 Aug; 17(8):1065-75. PubMed ID: 19254740
[TBL] [Abstract][Full Text] [Related]
19. Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma.
Nagai S; Washiyama K; Kurimoto M; Takaku A; Endo S; Kumanishi T
J Neurosurg; 2002 May; 96(5):909-17. PubMed ID: 12005399
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
Liu Y; Smith PW; Jones DR
Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
